Description
Cjc-1295 (No DAC) + Ipamorelin
This dual-peptide research formulation combines a growth hormone-releasing hormone pathway peptide with ipamorelin, a growth hormone secretagogue receptor agonist. These signaling systems are investigated in endocrine regulation and pituitary responses. Component identity and ratio should be verified through product-specific documentation.
Available strength: 10mg total nominal content.
FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
